Nasdaq · CIK 0002058707
ATTO Attovia Therapeutics, Inc.
Insider trading from SEC Form 4. Last filing 2 d ago.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
2
with a Form 4 at this company
Signals
Open-market buys and sells at Attovia Therapeutics, Inc., scored.
No scored open-market trades yet. Grants, exercises and other rows are below.
Transactions
The last 2 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 4, 2026 | Fu Tao President and CEO | AGrant or award Stock Option (Right to Buy)derivative | +538,300 | $0.00 | $0 | 538,300 | 2 d ago |
| Aug 4, 2026 | Chan Steven Chief Financial Officer | AGrant or award Stock Option (Right to Buy)derivative | +140,000 | $0.00 | $0 | 140,000 | 2 d ago |
Insiders
Everyone who has filed a Form 4 here.
- Chan StevenChief Financial Officer
- Fu TaoPresident and CEO
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.